Plano-based mostly Reata Pharmaceuticals Inc. is getting a $350 million infusion from a Wall Street titan to support in bringing its serious kidney condition drug to the industrial market place.…
Plano-based mostly Reata Pharmaceuticals Inc. is getting a $350 million infusion from a Wall Street titan to support in bringing its serious kidney condition drug to the industrial market place.…